Nektar Therapeutics | NKTR - Market Capitalization


Nektar Therapeutics reported $13.62B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 7.93B 806M Aug/2026
Alterity Therapeutics Limited AUD 39M 17M Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Baxter International USD 11.01B 2.34B Jun/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Cara Therapeutics USD 110M 80M Aug/2026
Cipla INR 1.18T 194.93B Jun/2026
Dr.Reddys Laboratories INR 1.13T 85.62B Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Exelixis USD 15.27B 1.73B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 324.18B 6.81B Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 153.17B 14.73B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Takeda JPY 8.2T 809.7B Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Xencor USD 1.21B 19M Aug/2026